Skip to main content

Table 2 Basic characteristics of patients who completed VascuQOL

From: Evaluation of vascular quality of life questionnaire in dialysis patients with peripheral arterial disease treated by low-density lipoprotein apheresis

  Age Gender D HD dur. Fontaine stage VascuQOL First LDL-A VascuQOL Tenth LDL-A VascuQOL One month
M
Non-CLI 68 Male (−) 21 II 4.24 4.12 2.36
66 Male (+) 14 II 5.36 5.28 5.44
74 Male (+) 4 II 5.68 6.24 6.24
74 Male (+) 6 II 5.44 5.6 5.84
73 Male (+) 7 II 3.88 4 4
80 Male (−) 5 II 2.36 2.88 2.56
51 Male (−) 9 II 4.72 4.48 5.48
70 Male (+) 1 II 5.72 5.88 5.36
73 Male (+) 7 II 5.56 6.04 5.76
63 Male (+) 20 II 1.64 3.04 2.96
68 Female (+) 12 II 4.6 5.36 5.52
68 Male (+) 1 II 5.92 5.4 5.48
78 Male (−) 22 II 5.84 5.88 5.44
70 Male (+) 1 II 6.04 6.24 6.48
CLI 76 Male (+) 2 III 2.68 2.92 3.28
57 Male (+) 7 IV 2.64 4.6 4.16
67 Male (+) 12 III 3.36 2.52 3.64
72 Female (+) 9 III 1.92 1.8 2.84
81 Male (+) 1 III 2.24 3.04 3.72
67 Female (+) 16 III 3.36 3.48 3.64
70 Male (+) 21 IV 6.04 6.64 6.76
64 Female (+) 1 IV 5.28 4.76 5.16
  1. HD dur. HD duration (years). One month 1 month after completion of LDL-A treatment